A citation-based method for searching scientific literature

Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 190



Theodore W Laetsch, Steven G DuBois, Leo Mascarenhas, Brian Turpin, Noah Federman, Catherine M Albert, Ramamoorthy Nagasubramanian, Jessica L Davis, Erin Rudzinski, Angela M Feraco, Brian B Tuch, Kevin T Ebata, Mark Reynolds, Steven Smith, Scott Cruickshank, Michael C Cox, Alberto S Pappo, Douglas S Hawkins. Lancet Oncol 2018
Times Cited: 218




List of shared articles



Times cited

Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.
Nathan D Seligson, Todd C Knepper, Susanne Ragg, Christine M Walko. Clin Pharmacol Ther 2021
7

Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Iva Brčić, Theresa Maria Godschachner, Marko Bergovec, Jasminka Igrec, Holger Till, Herwig Lackner, Susanne Scheipl, Karl Kashofer, Thomas Brodowicz, Andreas Leithner,[...]. Mod Pathol 2021
9

[Diagnosis and therapy of tumors with NTRK gene fusion].
Albrecht Stenzinger, Cornelis M van Tilburg, Ghazaleh Tabatabai, Florian Länger, Norbert Graf, Frank Griesinger, Lukas C Heukamp, Michael Hummel, Thomas Klingebiel, Simone Hettmer,[...]. Pathologe 2021
1

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
Sébastien Perreault, Rose Chami, Rebecca J Deyell, Dina El Demellawy, Benjamin Ellezam, Nada Jabado, Daniel A Morgenstern, Aru Narendran, Poul H B Sorensen, Jonathan D Wasserman,[...]. Curr Oncol 2021
2

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults.
D Gwyn Bebb, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet Feilotter, Aaron R Hansen, Martin Hyrcza, Monika Krzyzanowska,[...]. Curr Oncol 2021
3

Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion.
Roberto Filippi, Ilaria Depetris, Maria Antonietta Satolli. Expert Opin Pharmacother 2021
0

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.
P Garrido, R Hladun, E de Álava, R Álvarez, F Bautista, F López-Ríos, R Colomer, F Rojo. Clin Transl Oncol 2021
0

Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancers.
Alice Boilève, Loïc Verlingue, Antoine Hollebecque, Valérie Boige, Michel Ducreux, David Malka. Expert Opin Investig Drugs 2021
1

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
Ruiying Zhao, Feng Yao, Chan Xiang, Jikai Zhao, Zhanxian Shang, Lianying Guo, Wenjie Ding, Shengji Ma, Anbo Yu, Jinchen Shao,[...]. J Pathol Clin Res 2021
0

[How to test for NTRK gene fusions: A practical approach for pathologists].
Arnaud Uguen, Marie Csanyi-Bastien, Jean-Christophe Sabourin, Frédérique Penault-Llorca, Julien Adam. Ann Pathol 2021
0

MLH1/PMS2 Expression Could Tell Classical NTRK Fusion in Fluorescence In Situ Hybridization Positive Colorectal Carcinomas.
Yao Fu, Zheng Li, Fuping Gao, Jun Yang, Hongyan Wu, Biao Zhang, Xiaohong Pu, Xiangshan Fan. Front Oncol 2021
0

Update on Cutaneous Soft Tissue Tumors.
Josephine K Dermawan, Jennifer S Ko, Steven D Billings. Surg Pathol Clin 2021
0

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs.
Sun-Young Han. Pharmaceuticals (Basel) 2021
0

Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
Amélie Bourhis, Charline Caumont, Isabelle Quintin-Roué, Elsa Magro, Gurvan Dissaux, Annabelle Remoué, Pierre Le Noac'h, Nathalie Douet-Guilbert, Romuald Seizeur, Alexandra Tyulyandina,[...]. Pathology 2021
0

[Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours].
Federico Rojo, Ramón Colomer, Fernando López-Ríos, Francisco Bautista, Rosa Álvarez, Enrique de Álava, Raquel Hladun, Pilar Garrido. Rev Esp Patol 2021
0

Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Derek Wong, Stephen Yip, Poul H Sorensen. Pathol Oncol Res 2020
16

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
26

What's new in fibroblastic tumors?
Susan M Armstrong, Elizabeth G Demicco. Virchows Arch 2020
2

TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.
Ezra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, Ryma Benayed, Alison M Schram, Emiliano Cocco, Sophie Shifman, Yixiao Gong, Ritika Kundra, James P Solomon,[...]. Clin Cancer Res 2020
32



NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Joseph T Rabban, W Patrick Devine, Ankur R Sangoi, Liina Poder, Edwin Alvarez, Jessica L Davis, Erin Rudzinski, Karuna Garg, Gregory R Bean. Histopathology 2020
19

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, Stefano Gabriele Vallero, Matteo Monticelli, Fabio Cofano, Pietro Zeppa, Diego Garbossa, Alessia Pellerino, Roberta Rudà,[...]. Int J Mol Sci 2020
19

Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.
Yik Ka So, Chit Chow, Ka Fai To, John K C Chan, W Cheuk. Int J Surg Pathol 2020
8

TRK inhibition in soft tissue sarcomas: A comprehensive review.
Tarek Assi, Elie Rassy, Hussein Nassereddine, Fadi Farhat, Fadi El Karak, Joseph Kattan, Marwan Ghosn. Semin Oncol 2020
5

JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
T Yoshino, G Pentheroudakis, S Mishima, M J Overman, K-H Yeh, E Baba, Y Naito, F Calvo, A Saxena, L-T Chen,[...]. Ann Oncol 2020
25